Physiologically based pharmacokinetic modelling information
Graphic representation of a physiologically based whole body model. Here, it is dissected into seven tissue/organ compartments: brain, lungs and heart, pancreas, liver, gut, kidney and adipose/muscle tissue. Blood flows, Q, and concentration, [X], of a substance of interest are depicted.
Physiologically based pharmacokinetic (PBPK) modeling is a mathematical modeling technique for predicting the absorption, distribution, metabolism and excretion (ADME) of synthetic or natural chemical substances in humans and other animal species. PBPK modeling is used in pharmaceutical research and drug development, and in health risk assessment for cosmetics or general chemicals.
PBPK models strive to be mechanistic by mathematically transcribing anatomical, physiological, physical, and chemical descriptions of the phenomena involved in the complex ADME processes. A large degree of residual simplification and empiricism is still present in those models, but they have an extended domain of applicability compared to that of classical, empirical function based, pharmacokinetic models. PBPK models may have purely predictive uses, but other uses, such as statistical inference, have been made possible by the development of Bayesian statistical tools able to deal with complex models.[1] That is true for both toxicity risk assessment and therapeutic drug development.
PBPK models try to rely a priori on the anatomical and physiological structure of the body, and to a certain extent, on biochemistry. They are usually multi-compartment models, with compartments corresponding to predefined organs or tissues, with interconnections corresponding to blood or lymph flows (more rarely to diffusions). A system of differential equations for concentration or quantity of substance on each compartment can be written, and its parameters represent blood flows, pulmonary ventilation rate, organ volumes etc., for which information is available in scientific publications. Indeed, the description they make of the body is simplified and a balance needs to be struck between complexity and simplicity. Besides the advantage of allowing the recruitment of a priori information about parameter values, these models also facilitate inter-species transpositions or extrapolation from one mode of administration to another (e.g., inhalation to oral). An example of a 7-compartment PBPK model, suitable to describe the fate of many solvents in the mammalian body, is given in the Figure on the right.
^Gelman, A.; Bois, F.Y.; Jiang, J. (1996). "Physiological pharmacokinetic analysis using population modeling and informative prior distributions". Journal of the American Statistical Association. 91 (436): 1400–1412. CiteSeerX 10.1.1.44.2288. doi:10.1080/01621459.1996.10476708.
and 24 Related for: Physiologically based pharmacokinetic modelling information
Physiologicallybasedpharmacokinetic (PBPK) modeling is a mathematical modeling technique for predicting the absorption, distribution, metabolism and...
Fluorodeoxyglucose Multi-compartment model Patlak plot PharmacokineticsPhysiologically-basedpharmacokineticmodelling G. Lucignani; G. Paganelli; E. Bombardieri...
Neuroinformatics Mathematical model Compartmental models in epidemiology Physiologically-basedpharmacokineticmodelling Ermentrout, Bard; Terman H. David...
Physiologically-Based Pharmacokineticmodels integrate physiological information to simulate drug behavior in various tissues and organs. These models consider organ-specific...
45: 55–65. Franks S.J., Spendiff M.K., et al., 2006, Physiologicallybasedpharmacokineticmodelling of human exposure to 2-butoxyethanol, Toxicology Letters...
His research in pharmacology, has been particularly in physiologicallybasedpharmacokinetics (that deals with the movement in time of drugs and their...
M, Greig G, Reigner B, Parrott N (November 2016). "A PhysiologicallyBasedPharmacokineticModel for Ganciclovir and Its Prodrug Valganciclovir in Adults...
health record — Personalized medicine — Pharmacology — Physiologicallybasedpharmacokineticmodelling — Point of care testing — Positron emission tomography...
process parameters can then be integrated into so called "physiologicallybasedpharmacokineticmodels" or PBPK. In vitro studies permit a species-specific...
collaborated on earlier research published in 2008 used physiologicallybasedpharmacokineticmodelling (PBPK) to "evaluate the potential CYP3A4 inhibitory...
active metabolite. El-Masri HA, Portier CJ (June 1998). "Physiologicallybasedpharmacokineticsmodel of primidone and its metabolites phenobarbital and...
strong CYP3A4 inhibitor itraconazole, on the basis of physiologically-basedpharmacokineticmodeling, would be expected to increase daridorexant exposure...
1515/jip-2012-0081. Collins Licata, A.; et al. (2001). "A PhysiologicallyBasedPharmacokineticModel for Methyl tert-Butyl Ether in Humans: Implementing Sensitivity...
janagliflozin pharmacokinetics in type 2 diabetes mellitus patients with liver cirrhosis or renal impairment using a physiologicallybasedpharmacokineticmodel"....
tablets in specific populations clinical trials based on mechanistic physiologically-basedpharmacokineticmodel". European Journal of Pharmaceutical Sciences...
drugs and medications, including a substance's origin, composition, pharmacokinetics, pharmacodynamics, therapeutic use, and toxicology. More specifically...
naturally occurring steroid hormone, concerns its pharmacodynamics, pharmacokinetics, and various routes of administration. Estradiol is a naturally occurring...
the genetic control of alcohol dehydrogenase into a physiologicallybasedpharmacokineticmodel for ethanol in humans". Toxicological Sciences. 78 (1):...
Global Information